MedPath

Cevimeline Hydrochloride

CEVIMELINE HYDROCHLORIDE CAPSULES

Approved
Approval ID

51307f82-66f2-41c7-80ff-174d7e50f7ee

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 27, 2023

Manufacturers
FDA

Bryant Ranch Prepack

DUNS: 171714327

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Cevimeline Hydrochloride

PRODUCT DETAILS

NDC Product Code63629-9863
Application NumberANDA203775
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateAugust 3, 2018
Generic NameCevimeline Hydrochloride

INGREDIENTS (4)

CEVIMELINE HYDROCHLORIDEActive
Quantity: 30 mg in 1 1
Code: P81Q6V85NP
Classification: ACTIR
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
HYDROXYPROPYL CELLULOSE (1600000 WAMW)Inactive
Code: RFW2ET671P
Classification: IACT
© Copyright 2025. All Rights Reserved by MedPath
Cevimeline Hydrochloride - FDA Approval | MedPath